Mark G. Mishek: Pioneering Change in Addiction Treatment
We found out: well, it wasn't working so well when it came to our opioid use disorder patients. And we are saving lives by using suboxone is the trade name for it.
Ever wondered how one organization can lead the charge in transforming addiction treatment? In this episode of 'Let's Talk Addiction & Recovery', host William C. Moyers sits down with Mark G. Mishek, the President and CEO of the Hazelden Betty Ford Foundation. Mishek, a visionary in the field, discusses the foundation's innovative approaches to tackling addiction, from the opioid crisis to the use of suboxone in treatment.
He also touches on crucial topics like health insurance parity and the importance of partnerships in broadening the reach of effective treatments. Mishek doesn’t shy away from addressing the stigma surrounding addiction, emphasizing the need for public awareness and understanding that addiction is a disease, not a moral failing. His leadership has positioned Hazelden Betty Ford as a beacon of hope for countless individuals and families.
This episode is a must-listen for anyone interested in how collaborative efforts and innovative strategies can make a real difference in addiction recovery.